SLC18A2 and Parkinson disease: The inhibition of VMAT2 is similar to the beginning of PD as shown by Chen et al. (2008), who reported that MPTP administration into non-human primates induced a decrease in the striatal VMAT2 which preceded nigrostriatal dopamine neuron degeneration.